These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25960201)

  • 1. Estimation of the uncertainty of analyte concentration from the measurement uncertainty.
    Brown S; Cooke DG; Blackwell LF
    Scand J Clin Lab Invest; 2015 Sep; 75(5):367-73. PubMed ID: 25960201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective determination of appropriate reporting intervals.
    Badrick T; Wilson SR; Dimeski G; Hickman PE
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):385-90. PubMed ID: 15333190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rank-based estimate of four-parameter logistic model.
    Crimin KS; McKean JW; Vidmar TJ
    Pharm Stat; 2012; 11(3):214-21. PubMed ID: 22411779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating concentration estimation errors in ELISA microarray experiments.
    Daly DS; White AM; Varnum SM; Anderson KK; Zangar RC
    BMC Bioinformatics; 2005 Jan; 6():17. PubMed ID: 15673468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating uncertainty on internal dose assessments.
    Puncher M; Birchall A
    Radiat Prot Dosimetry; 2007; 127(1-4):544-7. PubMed ID: 17993651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying uncertainty of determination by standard additions and serial dilutions methods taking into account standard uncertainties in both axes.
    Hyk W; Stojek Z
    Anal Chem; 2013 Jun; 85(12):5933-9. PubMed ID: 23678943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing valid and optimised standard addition calibrations: Application to the determination of anions in seawater.
    Rodrigues J; da Silva RJ; Camões MF; Oliveira CM
    Talanta; 2015 Sep; 142():72-83. PubMed ID: 26003694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uncertainty of purity of reference materials must be known.
    Borges R; Meyer VR
    J Pharm Biomed Anal; 2013 Apr; 77():40-3. PubMed ID: 23384549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a design of experiment approach in the development of a sensitive bioanalytical assay in human plasma.
    Dawes ML; Bergum JS; Schuster AE; Aubry AF
    J Pharm Biomed Anal; 2012 Nov; 70():401-7. PubMed ID: 22776736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for parallelism in the heteroscedastic four-parameter logistic model.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2016; 26(2):250-68. PubMed ID: 25629201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of uncertainty of measurement in clinical biochemistry].
    Enea M; Hristodorescu C; Schiriac C; Morariu D; Mutiu T; Dumitriu I; Gurzu B
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):533-9. PubMed ID: 21495362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioassay case study applying the maximin D-optimal design algorithm to the four-parameter logistic model.
    Coffey T
    Pharm Stat; 2015; 14(5):427-32. PubMed ID: 26235135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance profiles: new tools for characterization and comparison of clinical chemical results.
    Keller H; Passing H
    J Clin Chem Clin Biochem; 1989 Sep; 27(9):613-29. PubMed ID: 2607322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational development and validation of a new microbiological assay for linezolid and its measurement uncertainty.
    Saviano AM; Francisco FL; Lourenço FR
    Talanta; 2014 Sep; 127():225-9. PubMed ID: 24913880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of measurement uncertainty for the quantification of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and its glucuronide in urine using liquid chromatography-tandem mass spectrometry.
    Kim JY; Kwon W; Kim HS; Suh S; In MK
    J Anal Toxicol; 2014 Apr; 38(3):164-70. PubMed ID: 24519562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical method for determining and comparing limits of detection of bioassays.
    Holstein CA; Griffin M; Hong J; Sampson PD
    Anal Chem; 2015 Oct; 87(19):9795-801. PubMed ID: 26376354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of variance function estimation on nonlinear calibration inference in immunoassay data.
    Belanger BA; Davidian M; Giltinan DM
    Biometrics; 1996 Mar; 52(1):158-75. PubMed ID: 8934590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between measurement uncertainty and reporting interval.
    Badrick T; Hawkins RC
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):177-9. PubMed ID: 24818615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.